Category: CUTTING EDGE
The case for testing serum neurofilament light protein in MS
What are the emerging treatments for neurofibromatosis?
What is the state of gene therapy for Parkinson’s disease?
3 exciting emerging interventional treatments for Parkinson’s disease
Are parasites the simple solution to the problem of MS?
What are the promising CSF biomarkers of MND?
10 things we now know about CIDP associated with anti NF155 antibodies
